PHAT vs RHI · rev $132.6M vs P/E 21, rev $5.38B
Phathom Pharmaceuticals Inc (PHAT) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
PHAT currently screens at market cap $622.7M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the PHAT and RHI stock pages for the full models.
Not investment advice.